Short/branched-chain acyl-CoA dehydrogenase deficiency due to an IVS3+3A>G mutation that causes exon skipping

被引:0
作者
Pia Pinholt Madsen
Maria Kibæk
Xavier Roca
Ravi Sachidanandam
Adrian R. Krainer
Ernst Christensen
Robert D. Steiner
K. Michael Gibson
Thomas J. Corydon
Inga Knudsen
Ronald J.A. Wanders
Jos P.N. Ruiter
Niels Gregersen
Brage Storstein Andresen
机构
[1] Aarhus University Hospital and Faculty of Health Science,Research Unit for Molecular Medicine
[2] Aarhus University,Institute of Human Genetics
[3] Odense University Hospital,Department of Pediatrics
[4] Cold Spring Harbor Laboratory,Department of Clinical Genetics
[5] Rigshospitalet,Departments of Molecular and Medical Genetics and Pediatrics, Biochemical Genetics Laboratory
[6] Oregon Health & Science University,Laboratory for Genetic Metabolic Diseases, Department of Clinical Chemistry and Pediatrics, Academic Medical Center
[7] University of Amsterdam,undefined
来源
Human Genetics | 2006年 / 118卷
关键词
SBCAD (; ) deficiency; IVS+3A>G mutation; 5′ splice site mutation; Exon skipping; Newborn screening;
D O I
暂无
中图分类号
学科分类号
摘要
Short/branched-chain acyl-CoA dehydrogenase deficiency (SBCADD) is an autosomal recessive disorder of l-isoleucine catabolism. Little is known about the clinical presentation associated with this enzyme defect, as it has been reported in only a limited number of patients. Because the presence of C5-carnitine in blood may indicate SBCADD, the disorder may be detected by MS/MS-based routine newborn screening. It is, therefore, important to gain more knowledge about the clinical presentation and the mutational spectrum of SBCADD. In the present study, we have studied two unrelated families with SBCADD, both with seizures and psychomotor delay as the main clinical features. One family illustrates the fact that affected individuals may also remain asymptomatic. In addition, the normal level of newborn blood spot C5-acylcarnitine in one patient underscores the fact that newborn screening by MS/MS currently lacks sensitivity in detecting SBCADD. Until now, seven mutations in the SBCAD gene have been reported, but only three have been tested experimentally. Here, we identify and characterize an IVS3+3A>G mutation (c.303+3A>G) in the SBCAD gene, and provide evidence that this mutation is disease-causing in both families. Using a minigene approach, we show that the IVS3+3A>G mutation causes exon 3 skipping, despite the fact that it does not appear to disrupt the consensus sequence of the 5′ splice site. Based on these results and numerous literature examples, we suggest that this type of mutation (IVS+3A>G) induces missplicing only when in the context of non-consensus (weak) 5′ splice sites. Statistical analysis of the sequences shows that the wild-type versions of 5′ splice sites in which +3A>G mutations cause exon skipping and disease are weaker on average than a random set of 5′ splice sites. This finding is relevant to the interpretation of the functional consequences of this type of mutation in other disease genes.
引用
收藏
页码:680 / 690
页数:10
相关论文
共 450 条
  • [1] Andresen BS(1997)The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype? Hum Mol Genet 6 695-707
  • [2] Bross P(2000)Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl- CoA dehydrogenase deficiency: identification of a new enzyme defect, resolution of its molecular basis, and evidence for distinct acyl-CoA dehydrogenases in isoleucine and valine metabolism Am J Hum Genet 67 1095-1103
  • [3] Udvari S(2004)Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene Hum Mutat 24 370-380
  • [4] Kirk J(2003)Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients J Med Genet 40 e82-1856
  • [5] Gray G(2003)Outcome of donor splice site mutations accounting for congenital afibrinogenemia reflects order of intron removal in the fibrinogen alpha gene (FGA) Blood 101 1851-279
  • [6] Kmoch S(1998)Hematologically important mutations: red cell pyruvate kinase (2nd update) Blood Cells Mol Dis 24 273-110
  • [7] Chamoles N(2001)Mutation analysis of the MCM gene in Israeli patients with mut(0) disease Mol Genet Metab 73 107-653
  • [8] Knudsen I(1994)A novel splice donor mutation affecting position +3 in intron 6 of the factor VIII gene Hum Mol Genet 3 651-2082
  • [9] Winter V(1995)Two alpha subunit donor splice site mutations cause human trifunctional protein deficiency J Clin Invest 95 2076-65
  • [10] Wilcken B(1991)Prediction of human mRNA donor and acceptor sites from the DNA sequence J Mol Biol 220 49-1292